Spots Global Cancer Trial Database for Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer
Official Title: Phase II Trial to Evaluate the Efficacy of Fostamatinib in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma(DLBCL)
Study ID: NCT01499303
Conditions
Interventions
Study Description
Brief Summary: This study will evaluate the effectiveness of fostamatinib (200 mg twice a day) in patients with worsening or unmanageable lymphoma with a specific type of lymphoma called Diffuse Large B-Cell Lymphoma (abbreviated as DLBCL)
Detailed Description: Phase II Trial to Evaluate the Efficacy of Fostamatinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Research Site, Huntsville, Alabama, United States
Research Site, Denver, Colorado, United States
Research Site, New Haven, Connecticut, United States
Research Site, Sarasota, Florida, United States
Research Site, Atlanta, Georgia, United States
Research Site, Iowa City, Iowa, United States
Research Site, Baltimore, Maryland, United States
Research Site, Boston, Massachusetts, United States
Research Site, Rochester, Minnesota, United States
Research Site, St. Louis, Missouri, United States
Research Site, Hackensack, New Jersey, United States
Research Site, New York, New York, United States
Research Site, Rochester, New York, United States
Research Site, Columbus, Ohio, United States
Research Site, Nashville, Tennessee, United States
Research Site, Houston, Texas, United States
Research Site, San Antonio, Texas, United States
Research Site, Charlottesville, Virginia, United States
Research Site, Seattle, Washington, United States
Research Site, London, , United Kingdom
Research Site, Southampton, , United Kingdom
Contact Details
Name: Bernadette Weidman, RN, MSN, PMP
Affiliation: Sponsor GmbH
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
